首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Preparation carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-34-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety
【2h】

Preparation carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-34-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety

机译:带有单或二肽部分的新型7-氨基-34-二氢喹啉-2(1H)-一衍生物的制备碳酸酐酶抑制和抗氧化活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

New dipeptide–dihydroquinolinone derivatives were successfully synthesised by benzotriazole mediated nucleophilic acyl substitution reaction and their structures were elucidated by spectroscopic and analytic techniques. The carbonic anhydrase (CA, EC 4.2.1.1) inhibitory activity of the new compounds was determined against four human (h) isoforms, hCA I, hCA II, hCA IX and hCA XII. While all compounds showed moderate to good CA inhibitory properties against hCA IX and hCA XII with inhibition constants in the micromolar level (37.7–86.8 and 2.0–8.6 µM, respectively), they did not show inhibitory activity against hCA I and hCA II up to 100 µM concentration. The antioxidant capacity of the peptide–dihydroquinolinone conjugates was determined using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Most of the synthesised compounds showed low antioxidant activities compared to the control antioxidant compounds BHA and α-tocopherol.
机译:通过苯并三唑介导的亲核酰基取代反应成功合成了新的二肽-二氢喹啉酮衍生物,并通过光谱和分析技术阐明了它们的结构。确定了新化合物对四种人(h)亚型hCA I,hCA II,hCA IX和hCA XII的碳酸酐酶(CA,EC 4.2.1.1)抑制活性。尽管所有化合物均显示出对hCA IX和hCA XII的中度至良好的CA抑制特性,且微摩尔水平的抑制常数(分别为37.7–86.8和2.0–8.6µM),但它们对hCA I和hCA II均没有抑制活性。浓度为100 µM。肽-二氢喹啉酮缀合物的抗氧化能力是通过1,1-二苯基-2-吡啶并肼基(DPPH)自由基清除方法测定的。与对照抗氧化剂化合物BHA和α-生育酚相比,大多数合成化合物显示出较低的抗氧化剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号